Robert J More's Net Worth

$9.93 Million

Estimate Recalculated Nov 11, 2024 02:54AM EST

Who is Robert J More?

Robert J More has an estimated net worth of $9.93 Million. This is based on reported shares across multiple companies, which include Volcano Corp, Orexigen Therapeutics, Inc., IOMAI CORP, Allakos Inc., GLAUKOS Corp, Tyra Biosciences, Inc., Vanda Pharmaceuticals Inc., Vir Biotechnology, Inc., NUVASIVE INC, Sienna Biopharmaceuticals, Inc., NOVACEA INC, CADENCE PHARMACEUTICALS INC, SANTARUS INC, Somaxon Pharmaceuticals, Inc., and Northstar Neuroscience, Inc..

SEC CIK

Robert J More's CIK is 0001207792

Past Insider Trading and Trends

2007 was Robert J More's most active year for acquiring shares with 3 total transactions. Robert J More's most active month to acquire stocks was the month of April. 2021 was Robert J More's most active year for disposing of shares, totalling 29 transactions. Robert J More's most active month to dispose stocks was the month of February. 2019 saw Robert J More paying a total of $250,000.00 for 185,822 shares, this is the most they've acquired in one year. In 2021 Robert J More cashed out on 105,948 shares for a total of $6,639,548.10, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allakos Inc. (ALLK) Snapshot price: $0.648

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-32.55K
$114.22
-$3,718,318.58
0
Mar 3 - Mar 5
Form 4
-100.00%
-11.54K
$71.58
-$825,938.82
0
May 18
Form 4
-8.32%
-958.55K
—
—
10.56M
Jan 22
Form 4
∞
11.52M
$18.00
—
11.52M
Jul 23
Form 3
—
0
—
—
0
No matching records found

Volcano Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.03%
-678.37K
$14.49
-$226,840.95
2.71M
Jul 16
Form 4
+33.16%
18.32K
—
—
73.56K
Apr 24
Form 4
-14.83%
-589.88K
$12.98
-$176,696.74
3.39M
Apr 8
Form 4
+2,866.60%
53.38K
—
—
55.24K
Sep 12
Form 4/A
∞
24.09K
—
—
24.09K
May 25
Form 4/A
-100.00%
-22.23K
$20.12
-$447,267.60
0
May 31
Form 4
-100.00%
-22.23K
$20.12
-$447,267.60
0
May 31
Form 4
∞
22.23K
—
—
22.23K
May 25
Form 4
-18.20%
-20.42K
$19.25
-$393,065.75
91.78K
May 18
Form 4
-15.18%
-721.17K
—
—
4.03M
May 10
Form 4/A
-15.47%
-889.69K
$16.75
-$14,902,307.50
4.86M
Dec 6
Form 4
-15.47%
-889.69K
$16.75
-$14,902,324.25
4.86M
Dec 6
Form 4
∞
5.75M
—
—
5.75M
Jun 20
Form 3
—
0
—
—
0
No matching records found

Orexigen Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-19.84%
-902.43K
$14.27
-$299,670.00
3.65M
Nov 27
Form 4
+1,649.54%
4.29M
$12.00
—
4.55M
May 1
Form 3
—
0
—
—
0
No matching records found

IOMAI CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.74M
—
—
1.74M
Feb 6
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $129.28

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5K
$18.00
$90,000.00
5K
Jun 24
Form 3
—
0
—
—
0
No matching records found